01 — Origin
Built from a personal conviction.
Cytosomatic Labs was founded to take complex neurological conditions seriously at the cellular level.
Founder
Founder, Cytosomatic Labs
Cytosomatic Labs began with a straightforward observation: patients with neurodegenerative and complex neurological conditions are asked to accept blunt, symptomatic treatments in a decade where neural biology can be read with remarkable precision. The gap is not ambition — it is disciplined, well-documented execution.
I started this organization to build that discipline first: rigorous protocols, honest reporting of what is and is not validated, and a neuroscience research platform that partners can inspect rather than take on trust.

The founder's view
01 — Origin
Cytosomatic Labs was founded to take complex neurological conditions seriously at the cellular level.
02 — Investment
The founder funds research that needs patience, rigour and a clear scientific rationale.
03 — Direction
Every decision is measured against one question: does this move neural medicine forward?
Operating principles
Every claim we publish traces back to a protocol, a dataset and a reviewer. Nothing is described as more mature than it is.
Neurodegenerative and complex neurological patients live with trade-offs that datasets rarely capture. Their experience sets our research priorities.
Small teams move faster with good partners. We design our work so that academic and clinical groups can plug in early.
Reproducibility, provenance and documentation are the substrate of credible science — not overhead to be optimised away.
I read every collaboration enquiry personally. Reach out through the contact form or connect with me directly on LinkedIn.